Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
900 studies found for:    (psychotic disorders OR schizophrenia) AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Completed
Has Results
Trial of D-Cycloserine in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: D-cycloserine;   Drug: Placebo
22 Completed Lithium Drug-Drug Interaction Study With Lurasidone HCl
Condition: Schizophrenia
Intervention: Drug: Lurasidone HCl
23 Completed The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women
Conditions: Post-Traumatic Stress Disorder;   Mental Disorders;   Depression
Interventions: Behavioral: Trauma Recovery and Empowerment Model (TREM);   Behavioral: Usual care
24 Completed A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia
Condition: Schizophrenia
Interventions: Drug: JNJ-37822681;   Other: Placebo
25 Completed A Study in Schizophrenia Patients
Condition: Schizophrenia
Interventions: Drug: Risperidone;   Drug: Placebo;   Drug: LY2140023
26 Completed The Bioequivalence Of Two Different Lurasidone Formulations In Patients
Condition: Schizophrenia
Intervention: Drug: Lurasidone HCl
27 Terminated A Study of LY2140023 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: LY2140023;   Drug: Placebo
28 Not yet recruiting Keeping Well:Online Cognitive Behavioral Therapy (CBT) for Pregnant Women With Depressive Symptoms
Conditions: Anxiety;   Mental Disorders;   Postpartum Depression;   Depressive Symptoms
Interventions: Behavioral: Online Cognitive Behavioral Therapy (CBT);   Other: Treatment as usual
29 Recruiting Pediatric Schizophrenia Efficacy and Safety Study
Condition: Schizophrenia
Interventions: Drug: Lurasidone 40 mg;   Drug: Lurasidone 80 mg;   Drug: Placebo 40 or 80 mg
30 Completed Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Interventions: Drug: Raloxifene hydrochloride;   Other: Lactose Capsules
31 Completed The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Interventions: Drug: Raloxifene;   Drug: Estradiol/dyhydroprogestrone
32 Recruiting The Topical Niacin Skin Flush Test in First Episode Psychosis
Conditions: Psychotic Disorders;   Schizophrenia
Intervention: Other: skin test
33 Recruiting Pediatric Open-Label Extension Study
Conditions: Schizophrenia;   Autism;   Bipolar Depression
Intervention: Drug: Lurasidone 20, 40, 60, 80 mg, flexibly dosed
34 Completed Risk Factors for Postpartum Psychosis
Conditions: Postpartum Period;   Psychosis
Intervention:
35 Completed Knowledge and Perception of Smoking Risks/Consequences
Conditions: Cigarette Smoking;   Schizophrenia
Intervention:
36 Completed In-Patient Study In Schizophrenic Patients
Condition: Schizophrenia
Intervention: Drug: SB773812
37 Completed Paternal Psychosis After Baby Born
Condition: Psychosis
Intervention: Other: Not available
38 Completed
Has Results
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
Conditions: Fatigue;   Iron Deficiency
Interventions: Drug: Ferrous sulphate;   Drug: Placebo
39 Completed Validation of the French Warwick-Edinburgh Mental Well-being Scale (WEMWBS)
Conditions: Human Characteristics;   Attitude to Health
Intervention:
40 Unknown  Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia
Condition: Schizophrenia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years